Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yi-Dan Yan

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Yi Chuan = Hereditas|November 24, 2020
[Functional analysis of CG8005 gene in Drosophila testis]Wan Yin Chen, Yi Dan Yan, Xiao Jin Luan, et al.
Frontiers in Pharmacology|July 2, 2021
Benefits and Harms of Low-Dose Rivaroxaban in Asian Patients With Atrial Fibrillation: A Systematic Review and Meta-analysis of Real-World StudiesJun Qian, Yi-Dan Yan, Sheng-Yan Yang, et al.
Frontiers in Immunology|October 17, 2022
Comparative efficacy and safety of JAK inhibitors as monotherapy and in combination with methotrexate in patients with active rheumatoid arthritis: A systematic review and meta-analysisLi Liu, Yi-Dan Yan, Fang-Hong Shi, et al.
Frontiers in Oncology|August 28, 2020
A Multiple Primary Malignancy Patient With FANCA Gene Mutation: A Case Report and Literature ReviewQing Xia, Ling-Yi Zhao, Yi-Dan Yan, et al.
Frontiers in Pharmacology|January 21, 2025
A network comparison on efficacy and safety profiling of PD-1/PD-L1 inhibitors in first-line treatment of advanced non-small cell lung cancerJie Fu, Yi-Dan Yan, Xu Wan, et al.
Translational Cancer Research|February 4, 2022
Rivaroxaban treatment for cancer-associated venous thromboembolism in a patient with heparin-induced thrombocytopenia: a case reportKe-Jia Le, Yi-Dan Yan, Yang-Xi Liu, et al.
International Journal of Clinical Pharmacy|November 16, 2022
Adherence to endocrine therapy in patients with hormone receptor-positive early-stage breast cancer: a retrospective studyYi-Dan Yan, Jie Fu, Zhi-Chun Gu, et al.
Biology of Reproduction|April 6, 2024
Association between ACE1 and missed abortion: ACE1 promotes H2O2-induced trophoblast cell injury in vitro†Yi-Dan Yan, Wen-Xia Ji, Na Zhao, et al.
Annals of Palliative Medicine|August 14, 2020
Successful thrombolytic therapy in acute ischemic stroke after reversal of warfarin: a case reportGang Qiu, Yi-Dan Yan, Xue-Feng Zhang, et al.
Frontiers in Pharmacology|June 28, 2018
Net Clinical Benefit of Non-vitamin K Antagonist Oral Anticoagulants for Venous Thromboembolism Prophylaxis in Patients With Cancer: A Systematic Review and Trade-Off Analysis From 9 Randomized Controlled TrialsYi-Dan Yan, Chi Zhang, Long Shen, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Yi Chuan = Hereditas|November 24, 2020
[Functional analysis of CG8005 gene in Drosophila testis]Wan Yin Chen, Yi Dan Yan, Xiao Jin Luan, et al.
Frontiers in Pharmacology|July 2, 2021
Benefits and Harms of Low-Dose Rivaroxaban in Asian Patients With Atrial Fibrillation: A Systematic Review and Meta-analysis of Real-World StudiesJun Qian, Yi-Dan Yan, Sheng-Yan Yang, et al.
Frontiers in Immunology|October 17, 2022
Comparative efficacy and safety of JAK inhibitors as monotherapy and in combination with methotrexate in patients with active rheumatoid arthritis: A systematic review and meta-analysisLi Liu, Yi-Dan Yan, Fang-Hong Shi, et al.
Frontiers in Oncology|August 28, 2020
A Multiple Primary Malignancy Patient With FANCA Gene Mutation: A Case Report and Literature ReviewQing Xia, Ling-Yi Zhao, Yi-Dan Yan, et al.
Frontiers in Pharmacology|January 21, 2025
A network comparison on efficacy and safety profiling of PD-1/PD-L1 inhibitors in first-line treatment of advanced non-small cell lung cancerJie Fu, Yi-Dan Yan, Xu Wan, et al.
Translational Cancer Research|February 4, 2022
Rivaroxaban treatment for cancer-associated venous thromboembolism in a patient with heparin-induced thrombocytopenia: a case reportKe-Jia Le, Yi-Dan Yan, Yang-Xi Liu, et al.
International Journal of Clinical Pharmacy|November 16, 2022
Adherence to endocrine therapy in patients with hormone receptor-positive early-stage breast cancer: a retrospective studyYi-Dan Yan, Jie Fu, Zhi-Chun Gu, et al.
Biology of Reproduction|April 6, 2024
Association between ACE1 and missed abortion: ACE1 promotes H2O2-induced trophoblast cell injury in vitro†Yi-Dan Yan, Wen-Xia Ji, Na Zhao, et al.
Annals of Palliative Medicine|August 14, 2020
Successful thrombolytic therapy in acute ischemic stroke after reversal of warfarin: a case reportGang Qiu, Yi-Dan Yan, Xue-Feng Zhang, et al.
Frontiers in Pharmacology|June 28, 2018
Net Clinical Benefit of Non-vitamin K Antagonist Oral Anticoagulants for Venous Thromboembolism Prophylaxis in Patients With Cancer: A Systematic Review and Trade-Off Analysis From 9 Randomized Controlled TrialsYi-Dan Yan, Chi Zhang, Long Shen, et al.
Pageof 3